Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1321157
Max Phase: Preclinical
Molecular Formula: C19H21ClN2O3
Molecular Weight: 360.84
Molecule Type: Small molecule
Associated Items:
ID: ALA1321157
Max Phase: Preclinical
Molecular Formula: C19H21ClN2O3
Molecular Weight: 360.84
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)C(Cc1ccccc1)NCC(=O)Nc1cccc(Cl)c1C
Standard InChI: InChI=1S/C19H21ClN2O3/c1-13-15(20)9-6-10-16(13)22-18(23)12-21-17(19(24)25-2)11-14-7-4-3-5-8-14/h3-10,17,21H,11-12H2,1-2H3,(H,22,23)
Standard InChI Key: RPRZFRPYVGJJBC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 360.84 | Molecular Weight (Monoisotopic): 360.1241 | AlogP: 2.96 | #Rotatable Bonds: 7 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.38 | CX Basic pKa: 4.90 | CX LogP: 3.69 | CX LogD: 3.68 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.74 | Np Likeness Score: -1.13 |
1. PubChem BioAssay data set, |
Source(1):